Article Listing - China's hep B market $800M by 2012

WHO BUDGET CRISIS IMPACT ON STAFF

6 April 1992

Staff of the World Health Organiz-ation, as a result of the budget crisis, are "deeply concerned not only about their...

STOCK MARKET COMMENTARY: EUROPE

6 April 1992

EUROPE: saw most bourses weak at the start of the reporting period, but strengthen as time went on. By the...

REDUCING ASTHMA COSTS IN THE USA

6 April 1992

A study looking at the economic aspect of asthma in the USA has found that there are a number of...

FURTHER FALLS FOR DEPRENYL?

6 April 1992

Shares of the Canadian biopharmaceutical company Deprenyl Re-search have recently lost value and could well fall further, according to local...

NEW PRES AT PROCORDIA

6 April 1992

Jan Ekberg has been named as president and chief executive at Procordia, in succession to Soren Gyll who has become...

ARIAD PHARMACEUTICALS STOCK SALE

6 April 1992

The biotechnology concern Ariad Pharmaceuticals of the USA is reported to have raised $46 million in a private stock sale,...

CHIROS ACQUIRES ENZYMATIX' CHIRAL DIV

6 April 1992

A new UK company, Chiros Ltd, was formed last month to purchase the assets and business of the Chiral division...

US PHARMACY COMPOUNDING GUIDE

6 April 1992

The US Food and Drug Administration has, for the first time, issued a pharmacist compounding compliance guide, due to the...

MAINTENANCE ULCER THERAPY CUT URGED

6 April 1992

A team of UK gastroenterologists have called for physicians to stop treating duodenal ulcer patients with maintenance H2 antagonist therapy....

ROMANIAN HEALTH SECTOR PLANS

6 April 1992

Romania's Minister of Health, Mircea Aiorescu, has announced in Bucharest that his Ministry is planning to change various aspects of...

Showing 94541-94550 of 95360 articles

Go to beginningPreviousNextGo to end